This project (fMRI) will use fMRI techniques to examine the functional integrity of the neuroanatomic networks subserving episodic memory and executive function, abilities that demonstrate significant impairment in prodromal AD. A series of fMRI experiments are planned to evaluate older controls and non-demented individuals with varying levels of cognitive impairment, who are at risk for progressing to meet clinical criteria for AD. Both block design and event-related paradigms will be employed. Experiments 1-3 will employ a face-name association memory paradigm, which had shown reliable activation in a specific functional network, that includes the anterior hippocampus, fusiform and prefrontal cortices. Experiment 4 is focused on the functional network activated during an executive function paradigm, a set-switching and interference task that has shown reliable activation in the anterior cingulate. By examining patterns of fMRI activation during episodic memory and executive function, we hope to elucidate the neural underpinnings of the cognitive dysfunction that occurs in prodromal D. We will test the hypothesis that alterations in the fMRI activation in specific regions can differentiate individuals with varying levels of cognitive impairment, and determine if longitudinal change in activation is associated with change in level of cognitive impairment. We will also examine the relationship of fMRI data to variables from other cores and projects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG004953-19
Application #
6548805
Study Section
Special Emphasis Panel (ZAG1-FAS-3 (M1))
Project Start
1984-08-01
Project End
2007-07-31
Budget Start
Budget End
Support Year
19
Fiscal Year
2002
Total Cost
$199,493
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Tosto, Giuseppe; Monsell, Sarah E; Hawes, Stephen E et al. (2016) Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates. J Alzheimers Dis 49:1085-93
Herold, C; Hooli, B V; Mullin, K et al. (2016) Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3. Mol Psychiatry 21:1608-1612
D'Avanzo, Carla; Aronson, Jenna; Kim, Young Hye et al. (2015) Alzheimer's in 3D culture: challenges and perspectives. Bioessays 37:1139-48
Weissmiller, April M; Natera-Naranjo, Orlangie; Reyna, Sol M et al. (2015) A ?-secretase inhibitor, but not a ?-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. PLoS One 10:e0118379
Liu, Qing; Waltz, Shannon; Woodruff, Grace et al. (2014) Effect of potent ?-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers. JAMA Neurol 71:1481-9
Liang, Steven H; Yokell, Daniel L; Jackson, Raul N et al. (2014) Microfluidic continuous-flow radiosynthesis of [(18)F]FPEB suitable for human PET imaging. Medchemcomm 5:432-435
Choi, Se Hoon; Kim, Young Hye; Hebisch, Matthias et al. (2014) A three-dimensional human neural cell culture model of Alzheimer's disease. Nature 515:274-8
Fung, Wai Lun Alan; Naylor, Melissa G; Bennett, David A et al. (2013) Principal components methods for narrow-sense heritability in the analysis of multidimensional longitudinal cognitive phenotypes. Am J Med Genet B Neuropsychiatr Genet 162B:770-8
Macklin, Eric A; Blacker, Deborah; Hyman, Bradley T et al. (2013) Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpoints. J Alzheimers Dis 36:475-86
Johnson, Keith A; Sperling, Reisa A; Gidicsin, Christopher M et al. (2013) Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement 9:S72-83

Showing the most recent 10 out of 104 publications